VMY-1-103

SKU: orb1738250

Description

VMY-1-103 is a potent dansylated CDK inhibitor derived from purvalanol B. It demonstrates superior antiproliferative and pro-apoptotic activity in vitro against prostate, breast, and medulloblastoma cancer cells by inducing cell cycle arrest and activating intrinsic and extrinsic apoptotic pathways.

Research Area

Cell Biology, Protein Biochemistry

Key Properties

• CAS Number: 1209002-43-6
• MW: 708.27
• Formula: C₃₄H₄₂ClN₉O₄S
• SMILES: N(C1=C2C(N(C(C)C)C=N2)=NC(N[C@H](C(C)C)CO)=N1)C3=CC(Cl)=C(C(NCCNS(=O)(=O)C=4C5=C(C(N(C)C)=CC=C5)C=CC4)=O)C=C3
• Target: Apoptosis,Caspase,Others

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

44626421